left

 

 

Investor Relations

Company Profile for Nutri Pharmaceuticals Research, Inc.
Friday September 21, 10:40 am ET

--(BUSINESS WIRE)--Nutri Pharmaceuticals Research, Inc. provides a wide range of powdered oils for functional food, food supplement; pharmaceutical; cosmetic; pet food and animal feed applications. The company is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2P(TM) Powderization process. The O2P(TM) Oil-to-Powder technology is a process that converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P(TM) does not rely on traditional techniques that utilize extremes in heat or cold, micro-encapsulation or nano technology. This facilitates food marketing and supplement producers' ability to create functional foods and nutraceuticals by adding anti-oxidants, specific EFAs, or other fatty acids such as EPA, GLA, DHA, and CLA to assist in maintaining specific health issues. The company currently offers more than 50 shelf-stable powders. The company can also apply O2P(TM) technology to a third-party's oil, paste or gel through an arrangement called tolling.
 

Company: Nutri Pharmaceuticals Research, Inc.

Headquarters Address: 6780 Caballo Street
Las Vegas, NV 89119

Main Telephone: 702-309-8627
Website: www.o2pus.com

Ticker: NRPR(PINK SHEETS)

Type of Organization: Public IRPR

Industry: Biotechnology
Key Executives: CEO: Godfrey Yew
Director I.R.: Fabio Sunago

Investor Relations
Contact: Fabio Sunago
Phone: 702-309-8627

Investor Relations
Contact: Mike King
Phone: 702-650-3000
 

--------------------------------------------------------------------------------
Source: Nutri Pharmaceuticals Research, Inc.


Click here to get News Releases NPRI Reports Record First Quarter Earnings

left

 

 

 

O2P™ is a trademark of NPRI  |  ©1994 - 2009 Nutri Pharmaceuticals Research, Inc. (NPRI) Investor Relations